These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7591356)

  • 1. Monitoring in methadone maintenance treatment.
    Baker JG; Rounds JB; Carson CA
    Int J Addict; 1995 Jul; 30(9):1177-85. PubMed ID: 7591356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program.
    Avants SK; Margolin A; Mckee S
    J Subst Abuse; 2000; 11(3):215-30. PubMed ID: 11026121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing opiate abstinence through voucher-based reinforcement therapy.
    Silverman K; Wong CJ; Higgins ST; Brooner RK; Montoya ID; Contoreggi C; Umbricht-Schneiter A; Schuster CR; Preston KL
    Drug Alcohol Depend; 1996 Jun; 41(2):157-65. PubMed ID: 8809505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone dosages and therapeutic compliance during a methadone maintenance program.
    Maremmani I; Nardini R; Zolesi O; Castrogiovanni P
    Drug Alcohol Depend; 1994 Jan; 34(2):163-6. PubMed ID: 8026304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detected heroin use in an Australian methadone maintenance program.
    Caplehorn JR; Reilly DK; Wodak A
    J Subst Abuse Treat; 1993; 10(6):553-9. PubMed ID: 8308940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of contingency contracting for illicit drug use in a methadone maintenance program.
    Saxon AJ; Calsyn DA; Kivlahan DR; Roszell DK
    Drug Alcohol Depend; 1993 Feb; 31(3):205-14. PubMed ID: 8384984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple predictors of illicit drug use in methadone maintenance clients.
    Gollnisch G
    Addict Behav; 1997; 22(3):353-66. PubMed ID: 9183505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone dose and heroin use during maintenance treatment.
    Caplehorn JR; Bell J; Kleinbaum DG; Gebski VJ
    Addiction; 1993 Jan; 88(1):119-24. PubMed ID: 8448501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What happens when contingency management treatment ends? A tale of two clients.
    Petry NM; Kelley L; Brennan M; Sierra S
    Am J Addict; 2008; 17(3):241-4. PubMed ID: 18464002
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled use of heroin in patients on methadone maintenance treatment.
    Bianchi E; Maremmani I; Meloni D; Tagliamonte A
    J Subst Abuse Treat; 1992; 9(4):383-7. PubMed ID: 1479633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
    Preston KL; Umbricht A; Epstein DH
    Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
    Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
    Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contingency contracting and systematic desensitization for heroin addicts in methadone maintenance programs.
    Piane G
    J Psychoactive Drugs; 2000; 32(3):311-9. PubMed ID: 11061683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Client engagement and change during drug abuse treatment.
    Simpson DD; Joe GW; Rowan-Szal G; Greener J
    J Subst Abuse; 1995; 7(1):117-34. PubMed ID: 7655308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine testing in methadone maintenance treatment: applications and limitations.
    Goldstein A; Brown BW
    J Subst Abuse Treat; 2003 Sep; 25(2):61-3. PubMed ID: 14629984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.
    Peles E; Schreiber S; Sason A; Adelson M
    J Addict Med; 2011 Jun; 5(2):92-8. PubMed ID: 21769054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of illicit drug use and retention in a methadone program: a longitudinal study.
    Davstad I; Stenbacka M; Leifman A; Beck O; Korkmaz S; Romelsjö A
    J Opioid Manag; 2007; 3(1):27-34. PubMed ID: 17367092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.